VR Logo

ProPhase Labs Inc. (DE) (PRPH) download report


Healthcare | Drugs & Pharma

ProPhase Labs Inc. (DE) (PRPH) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States.

IPO Date: 16-Jan-1997

Chairman & CEO: Mr. Ted William Karkus

Chief Accounting Officer: Ms. Monica Brady

Listing: NASDAQ: PRPH

Country: United States

Headquarters: Garden City, NY

Website: https://www.prophaselabs.com

Key Facts

Market cap: $178.65 Mln

Revenue (TTM): $111.30 Mln

Earnings (TTM): $17.71 Mln

Cash: $29.35 Mln

Total Debt: $12.80 Mln

Insider's Holding: 19.02%

Liquidity: Low

52 Week range: $4.76 - 15.24

Shares outstanding: 15,685,100

10 Years Aggregate:

  • CFO: $-33.79 Mln
  • EBITDA: $18.24 Mln
  • Net Profit: $26.11 Mln

Stock Performance

Time Period ProPhase Labs Inc. (DE) (PRPH) S&P BSE Healthcare* S&P Small-Cap 600*
YTD50.70-11.26-12.41
1 month-23.265.347.33
3 months52.831.471.57
1 Year48.62-11.82-9.48
3 Years74.8922.769.22
5 Years39.7110.867.59
10 Years25.4412.2710.53
As on 09-Aug-2022 *As on 08-Aug-2022
Year ProPhase Labs Inc. (DE) (PRPH) S&P Small-Cap 600 S&P BSE Healthcare
2021-21.9025.2720.87
2020365.999.5761.45
2019-37.4620.86-3.55
201844.87-9.70-5.89
20178.5011.730.49
201633.3324.74-12.88
20152.74-3.3615.06